GLG Pharmasigns license agreement with a University and Medical center for the non-exclusive use of ovarian cancer cell culturing media and ovarian cancer cell variants. The license will be used with its development partner Precision Therapeutics subsidiary TumorGenesis. GLG is responsible for incorporating the new media into its proprietary Gx-C3 technology to help categorize patients and select the best oncology treatment combinations and doses from the FDA drug combination aspect of the business. TumorGenesis is focused on the Clinical Research market for clinical trials and the discovery and development of new drugs. Richard Gabriel, COO & Cofounder of GLG Pharma is also on the board of directors for Precision Therapeutics and has been asked to help build out the TumorGenesis technologies for the CRO market. GLG are partnered with Precision Therapeutics to advance these new technologies. Market opportunities are estimated to be substantial for CRO and for GLG's combination therapies to inhibit ovarian drug resistant tumors. 14 ovarian tumor types, representing 90% of ovarian cancers will be tested and new markers identified.
Wefunder supports three different federal laws that allow startups to raise money legally. To comply with the law, Wefunder Advisors LLC and Wefunder Portal LLC (both owned by Wefunder Inc) also list startups depending on the regulation used.
Legal May 16th 2016
Wefunder Portal LLC
for 314 startups
Wefunder Advisors LLC
for 105 startups
for 3 startups
Curious how well the companies have done? Or how many raised follow-on financing?
Some fine print: 1) These numbers include startups currently live on Wefunder if they pass their minimum target. 2) Some startups use two different laws at the same time (i.e., Regulation D and Regulation Crowdfunding).
Join 490,862 investors who funded 401 startups with over $143.5 million1
wefunder.com/updates/96109-glg-pharm-signs-license is managed by
Wefunder Portal LLC.
Wefunder Inc. runs wefunder.com and is the parent company of Wefunder Advisors LLC and Wefunder Portal LLC. Wefunder Advisors is an exempt reporting adviser that advises SPVs used in Reg D offerings. Wefunder Portal is a funding portal (CRD #283503) that operates sections of wefunder.com where some Regulation Crowdfunding offerings are made.
Wefunder, Inc. operates sections of wefunder.com where some Regulation D and A offerings are made. Wefunder, Inc. is not regulated as either a broker-dealer or funding portal and is not a member of FINRA.
You may also view our Privacy Notice.